Ricardo Viana

Ricardo Viana has a strong background in the pharmaceutical industry, with a focus on market access and healthcare systems. Ricardo began their career as a Pharmacist Consultant at Pharsolution before working as a Technical Director at Sigmimune - Produtos Clínicos e Farmacêuticos. Ricardo then pursued their PhD in Pharmacy specializing in Biochemistry at the Faculty of Pharmacy, University of Lisbon, PT, and the School of Medicine, New York University. After completing their education, Ricardo worked as a Procurement Manager & Clinical Advisor at Ametic. In 2011, they joined Novartis and held several roles, including Market Access Specialist, Healthcare Systems MA Manager, Global Market Access & HEOR Director, WorldWide Market Access Director, and Market Access Head in Norway. In 2018, they joined Novartis Oncology as the Global Access Product Lead and later became the Executive Director for Global Value and Access Disease Team Lead. Currently, Ricardo is the VP of Market Access EMEA at ImmunoGen, Inc.

Ricardo Viana has an education history that includes a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from the University of Lisbon & NYU School of Medicine, which they completed between 2006 and 2011. Prior to that, they pursued Drug delivery research (hepatitis B) at The School of Pharmacy, University of London in 2005. Ricardo obtained a PharmD in Pharmaceutical Sciences from Universidade de Coimbra from 1999 to 2005. In 1998, they completed their first year of a Psychology degree at Universidade de Coimbra.